11 17 WPI (Mirtazapine 15 mg)

Pill imprint 11 17 WPI has been identified as Mirtazapine 15 mg.

Mirtazapine is used in the treatment of depression; insomnia; anxiety; post traumatic stress disorder; hot flashes (and more), and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 15 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for 11 17 WPI (Mirtazapine 15 mg)

Mirtazapine 15 mg 11 17 WPI Front
Mirtazapine 15 mg 11 17 WPI Back
Mirtazapine 15 mg 11 17 WPI
11 17
15 mg
10.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Tetracyclic antidepressants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Watson Pharmaceuticals
National Drug Code (NDC):
Inactive Ingredients:
lactose anhydrous
silicon dioxide
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
polyethylene glycol 400
polysorbate 80
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
63874-1098 Altura Pharmaceuticals Inc (repackager)
58016-0894 Southwood Pharmaceuticals Inc (repackager)
16590-0153 Stat RX USA LLC (repackager)
68258-7004 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)